SUBSTITUIERTE XANTHINDERIVATE

European patent · EP2473053 · Deleted

Register entry

Publication number
EP2473053
Application number
EP10814504
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 2, 2010
Published
Jul 11, 2012
Granted
Apr 22, 2015
Deleted
Sep 30, 2016
Reason
Annual fee unpaid
IPC classes
C07D 473/04 (2006.01)
A61K 31/522 (2006.01)
A61P 13/12 (2006.01)
Priority
US 239342 P 02.09.2009
US 873991 01.09.2010
PCT application
PCT/US2010/047708 02.09.2010
PCT publication
WO2011/028922 10.03.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 19, 2017

    Deleted, fee unpaid

    Published in Swissreg on 19.04.2017

  2. Apr 22, 2015

    Granted

    Published in Swissreg on 22.04.2015

Parties

Holder

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc.

99 Hayden Avenue, Suite 500, Lexington, MA 02421, US

Inventor

TUNG, Roger D.

Lexington Massachusetts 02420, US

LIU, Julie F.

Lexington Massachusetts 02420, US

HARBESON, Scott L.

Cambridge Massachusetts 02140, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.